Cartesian Therapeutics, Inc. - Common Stock (RNAC)

CUSIP: 816212302

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
26,621,699
Total 13F shares
6,665,799
Share change
-204,176
Total reported value
$119,478,509
Price per share
$17.91
Number of holders
64
Value change
-$2,692,613
Number of buys
37
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 816212302?
CUSIP 816212302 identifies RNAC - Cartesian Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cartesian Therapeutics, Inc. - Common Stock (RNAC) as of Q4 2024

As of 31 Dec 2024, Cartesian Therapeutics, Inc. - Common Stock (RNAC) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,665,799 shares. The largest 10 holders included FMR LLC, MPM BIOIMPACT LLC, BlackRock, Inc., Siren, L.L.C., VANGUARD GROUP INC, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Erste Asset Management GmbH, and STATE STREET CORP. This page lists 64 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.